WAM User Manual Rev H1 V1.60 Feb 2016
32 Pages
Preview
Page 1
REF 9515-174-50-ENG Rev H1
WAM WIRELESS ACQUISITION MODULE
USER MANUAL
Manufactured by Mortara Instrument, Inc., Milwaukee, Wisconsin U.S.A. CAUTION: Federal law restricts this device to sale by or on the order of a physician.
Copyright © 2018 by Mortara Instrument, Inc. 7865 N. 86th Street Milwaukee, Wisconsin 53224
This document contains confidential information that belongs to Mortara Instrument, Inc. No part of this document may be transmitted, reproduced, used, or disclosed outside of the receiving organization without the express written consent of Mortara Instrument, Inc. Mortara is a registered trademark of Mortara Instrument, Inc. ELI and WAM are trademarks of Mortara Instrument, Inc. V1.60, 2016-Feb
TABLE OF CONTENTS TECHNICAL SUPPORT AND SERVICE... 1 NOTICES ... 2 WARRANTY INFORMATION ... 3 YOUR MORTARA WARRANTY ...3 USER SAFETY INFORMATION... 5 FCC COMPLIANCE STATEMENT ...8 INDUSTRY CANADA COMPLIANCE STATEMENT...8 EQUIPMENT SYMBOLS AND MARKINGS... 11 SYMBOL DELINEATION ...11 GENERAL CARE... 12 PRECAUTIONS ...12 INSPECTION ...12 STERILIZATION...12 CAUTIONS ...12 ELECTROMAGNETIC COMPATIBILITY (EMC)... 13 INTRODUCTION ... 17 MANUAL PURPOSE ...17 AUDIENCE ...17 INDICATIONS FOR USE ...17 SYSTEM DESCRIPTION ...17 WAM WITH LEAD WIRES ...18 USING THE BUTTONS...18 APPROVED BATTERY MODELS ...18 PART NUMBERS ...19 SPECIFICATIONS...20 EQUIPMENT PREPARATION ... 21 BATTERY INSTALLATION ...21 APPLYING POWER...21 ATTACHING THE LEAD WIRE CONNECTOR BLOCK ...21 LABELING THE WAM AND ELECTROCARDIOGRAPH...22 PAIRING WITH AN ELI 150C/ELI 250C ...22 PAIRING WITH AN ELI 230 ...22 PAIRING WITH AN ELI 280 ...22 PAIRING WITH AN ELI 350 ...23 LEAD FAIL ...24 LED INDICATORS ...24 ACQUIRING AN ECG ... 25 MAINTENANCE ... 26 CLEANING AND DISINFECTING THE WAM ...26
PERIODIC MAINTENANCE ...26 DISPOSAL OF WASTE MATERIALS...26 MESSAGES AND INFORMATION ... 27 SYSTEM INFORMATION LOG ...28 SERIAL AND PART NUMBER LOCATION ...28
TECHNICAL SUPPORT AND SERVICE Headquarters Mortara Instrument, Inc. 7865 North 86th Street Milwaukee, WI 53224 U.S.A. Tel: 414.354.1600 Tel: 800.231.7437 Fax: 414.354.4760 Internet: http://www.mortara.com
European Union Representative Via Cimarosa, 103/105 40033 Casalecchio di Reno (Bologna) Italia Tel: +39 051 2987811 Fax: +39 051 6133582 E-mail: clienti.mortarait @ welchallyn.com
Service/Technical Support Group Mortara Instrument, Inc. 7865 North 86th Street Milwaukee, WI 53224 U.S.A. Tel: 414.354.1600 Service: 888.MORTARA (888.667.8272) Fax: 414.354.4760 E-mail: [email protected] 24-hour Technical Support Same-day Shipment of Replacement Parts Biomedical Training Classes Extended Warranties/Service Contracts
Sales Support/ Supplies & Accessories Mortara Instrument, Inc. 7865 North 86th Street Milwaukee, WI 53224 U.S.A. Tel: 414.354.1600 Fax: 414.354.4760 Hospital Customers: Physician Practice: U.S. Distribution:
[email protected] [email protected] [email protected]
Mortara Instrument Germany Hofgartenstraße 16 72379 Hechingen Deutschland Tel.: +49 (0) 7471 98 41 14-0 Fax: +49 (0) 7471 98 41 14-90 E-Mail: info @ welchallyn.com Mortara Instrument Netherlands “Amerika” Gebouw– 7e verdieping Hoogoorddreef 15 1101 BA Amsterdam Nederland Tel.: 020 206 1360 E-mail: infonl @ welchallyn.com Mortara Instrument Australia Head Office Suite 4.01, 2-4 Lyonpark Road Macquarie Park, Sydney NSW 2113 Australia Tel: 1800 650 083 Fax: +61 2 9562 0982 Mortara Instrument UK Clinitron House, Excelsior Road Ashby de la Zouch Leicester LE65 1JG Tel: 0207 365 6780 Fax: 0207 365 9694
1
NOTICES Manufacturer’s Responsibility Mortara Instrument, Inc. is responsible for the effects on safety and performance only if: •
Assembly operations, extensions, readjustments, modifications, or repairs are carried out only by persons authorized by Mortara Instrument, Inc.
•
The device is used in accordance with the instructions for use.
Responsibility of the Customer The user of this device is responsible for ensuring the implementation of a satisfactory maintenance schedule. Failure to do so may cause undue failure and possible health hazards. Equipment Identification Mortara Instrument, Inc. equipment is identified by a serial and reference number on the back of the device. Care should be taken so that these numbers are not defaced. Copyright and Trademark Notices This document contains information that is protected by copyright. All rights are reserved. No part of this document may be photocopied, reproduced, or translated to another language without prior written consent of Mortara Instrument, Inc. Other Important Information The information in this document is subject to change without notice. Mortara Instrument, Inc. makes no warranty of any kind with regard to this material including, but not limited to, implied warranties of merchantability and fitness for a particular purpose. Mortara Instrument, Inc. assumes no responsibility for any errors or omissions that may appear in this document. Mortara Instrument, Inc. makes no commitment to update or to keep current the information contained in this document.
2
WARRANTY INFORMATION Your Mortara Warranty MORTARA INSTRUMENT, INC. (hereafter referred to as “Mortara”) warrants that components within Mortara products (hereafter referred to as “Product/s”) will be free from defects in workmanship and materials for the number of years specified on documentation accompanying the product, or previously agreed to by the purchaser and Mortara, or if not otherwise noted, for a period of twelve (12) months from the date of shipment. Consumable, disposable or single use products such as, but not limited to, PAPER or ELECTRODES are warranted to be free from defects in workmanship and materials for a period of 90 days from the date of shipment or the date of first use, whichever is sooner. Reusable product such as, but not limited to, BATTERIES, BLOOD PRESSURE CUFFS, BLOOD PRESSURE HOSES, TRANSDUCER CABLES, Y-CABLES, PATIENT CABLES, LEAD WIRES, MAGNETIC STORAGE MEDIUMS, CARRY CASES or MOUNTS, are warranted to be free from defects in workmanship and materials for a period of 90 days. This warranty does not apply to damage to the Product/s caused by any or all of the following circumstances or conditions: a)
Freight damage;
b) Parts and/or accessories of the Product/s not obtained from or approved by Mortara; c)
Misapplication, misuse, abuse, and/or failure to follow the Product/s instruction sheets and/or information guides;
d) Accident; a disaster affecting the Product/s; e)
Alterations and/or modifications to the Product/s not authorized by Mortara;
f)
Other events outside of Mortara’s reasonable control or not arising under normal operating conditions.
THE REMEDY UNDER THIS WARRANTY IS LIMITED TO THE REPAIR OR REPLACEMENT WITHOUT CHARGE FOR LABOR OR MATERIALS, OR ANY PRODUCT/S FOUND UPON EXAMINATION BY MORTARA TO HAVE BEEN DEFECTIVE. This remedy shall be conditioned upon receipt of notice by Mortara of any alleged defects promptly after discovery thereof within the warranty period. Mortara’s obligations under the foregoing warranty will further be conditioned upon the assumption by the purchaser of the Product/s (i) of all carrier charges with respect to any Product/s returned to Mortara’s principal place or any other place as specifically designated by Mortara or an authorized distributor or representative of Mortara, and (ii) all risk of loss in transit. It is expressly agreed that the liability of Mortara is limited and that Mortara does not function as an insurer. A purchaser of a Product/s, by its acceptance and purchase thereof, acknowledges and agrees that Mortara is not liable for loss, harm, or damage due directly or indirectly to an occurrence or consequence therefrom relating to the Product/s. If Mortara should be found liable to anyone under any theory (except the expressed warranty set forth herein) for loss, harm, or damage, the liability of Mortara shall be limited to the lesser of the actual loss, harm, or damage, or the original purchase price of the Product/s when sold.
3
EXCEPT AS SET FORTH HEREIN WITH RESPECT TO REIMBURSEMENT OF LABOR CHARGES, A PURCHASER’S SOLE EXCLUSIVE REMEDY AGAINST MORTARA FOR CLAIMS RELATING TO THE PRODUCT/S FOR ANY AND ALL LOSSES AND DAMAGES RESULTING FROM ANY CAUSE SHALL BE THE REPAIR OR REPLACEMENT OF DEFECTIVE PRODUCT/S TO THE EXTENT THAT THE DEFECT IS NOTICED AND MORTARA IS NOTIFIED WITHIN THE WARRANTY PERIOD. IN NO EVENT, INCLUDING THE CLAIM FOR NEGLIGENCE, SHALL MORTARA BE LIABLE FOR INCIDENTAL, SPECIAL, OR CONSEQUENTIAL DAMAGES, OR FOR ANY OTHER LOSS, DAMAGE, OR EXPENSE OF ANY KIND, INCLUDING LOSS OF PROFITS, WHETHER UNDER TORT, NEGLIGENCE OR STRICT LIABILITY THEORIES OF LAW, OR OTHERWISE. THIS WARRANTY IS EXPRESSLY IN LIEU OF ANY OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO THE IMPLIED WARRANTY OF MERCHANTABILITY AND THE WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE.
4
USER SAFETY INFORMATION Warning:
Means there is the possibility of personal injury to you or others.
Caution:
Means there is the possibility of damage to the device.
Note:
Provides information to further assist in the use of the device.
Warning(s) •
This manual gives important information about the use and safety of this device. Deviating from operating procedures, misuse or misapplication of the device, or ignoring specifications and recommendations could result in increased risk of harm to users, patients and bystanders, or damage to the device.
•
Device transmits data reflecting a patient’s physiological condition to a properly equipped receiving device that when reviewed by a trained physician or clinician can be useful in determining a diagnosis; however, the data should not be used as a sole means for determining a patient’s diagnosis.
•
Users are expected to be licensed clinical professionals knowledgeable about medical procedures and patient care, and adequately trained in the use of this device. Before attempting to use this device for clinical applications, the operator must read and understand the contents of the user manual and other accompanying documents. Inadequate knowledge or training could result in increased risk of harm to users, patients and bystanders, or damage to the device. Contact Mortara service for additional training options.
•
To maintain designed operator and patient safety, peripheral equipment and accessories used that can come in direct patient contact must be in compliance with UL 60601-1, IEC 60601-1, and IEC 60601-2-25. Only use parts and accessories supplied with the device and available through Mortara Instrument, Inc.
•
Patient cables intended for use with the device include series resistance (9 Kohm minimum) in each lead for defibrillation protection. Patient cables should be checked for cracks or breakage prior to use.
•
Conductive parts of the patient cable, electrodes, and associated connections of type CF applied parts, including the neutral conductor of the patient cable and electrodes, should not come into contact with other conductive parts including earth ground.
•
ECG electrodes could cause skin irritation; patients should be examined for signs of irritation or inflammation.
•
To avoid the possibility of serious injury or death during patient defibrillation, do not come into contact with device or patient cables. Additionally, proper placement of defibrillator paddles in relation to the electrodes is required to minimize harm to the patient.
•
Defibrillation protection is guaranteed only if the original patient cable is used. Any modification of this device may alter defibrillator protection.
•
To avoid potential for spread of disease or infection, single-use disposable components (e.g., electrodes) must not be reused. To maintain safety and effectiveness, electrodes must not be used beyond their expiration date.
•
This device was designed to use the electrodes specified in this manual. Proper clinical procedure must be employed to prep the electrode sites and to monitor the patient for excessive skin irritation, inflammation, or
5
USER SAFETY INFORMATION
other adverse reactions. Electrodes are intended for short-term use and should be removed from the patient promptly following testing. ●
FCC Warning (Part 15.21): Changes or modifications not expressly approved by the party responsible for compliance could void the user’s authority to operate the device.
•
A possible explosion hazard exists. Do not use the device in the presence of a flammable anesthetic mixture.
•
The device has not been designed for use with high-frequency (HF) surgical equipment and does not provide a protective means against hazards to the patient.
•
The quality of the signal produced by the device may be adversely affected by the use of other medical equipment, including but not limited to defibrillators and ultrasound machines.
•
There is no known safety hazard if other equipment, such as pacemakers or other stimulators, is used simultaneously with the device; however, disturbance to the signal may occur.
•
Operations may be affected in the presence of strong electromagnetic sources such as electrosurgery equipment.
•
The battery operated device transmits data reflecting a patient’s physiological condition to a receiving device. During operation failure, data transmission and LCD information will cease to occur. In mission critical conditions, it is advisable to have a backup device available.
•
Use only recommended alkaline battery cells. Use of other cells may present a risk of fire or explosion.
•
Low battery warning function is designed for alkaline battery cells only. Use of other cells may result in failure of the low battery warning possibly resulting in a malfunction of the device.
•
Do not attempt to clean the device or patient cables by submersing into a liquid, autoclaving, or steam cleaning as this may damage equipment or reduce its usable life. Use of unspecified cleaning/disinfecting agents, failure to follow recommended procedures, or contact with unspecified materials could result in increased risk of harm to users, patients and bystanders, or damage to the device. Do not sterilize the device or patient cables with Ethylene Oxide (EtO) gas.
•
The ELI 350 does not automatically switch between the device and a direct patient cable. Clinician must choose the desired cable in the Settings menu before ECG acquisition. Switching between a direct patient cable and the device does not require the device to be re-paired with the ELI 350 unless a different device is to be used. The selected patient cable will display continuously under the Settings menu button.
•
The minimum amplitude of the patient physiological signal that the ME equipment or system accepts is 30 μV. Operation of the ME equipment or ME system below this amplitude may cause inaccurate results.
6
USER SAFETY INFORMATION
Caution(s) •
To prevent possible damage to the device, do not use sharp or hard objects to depress buttons, only use fingertips.
•
The device and lead wires should be cleaned between each use. Inspect connections for damage or excessive wear prior to each use. Replace lead wires if damage or excessive wear is noted.
•
Do not pull or stretch patient cables as this could result in mechanical and/or electrical failures. Lead wires should be stored after forming them into a loose loop.
•
The device will only work with receiving devices that are equipped with the appropriate option.
•
No user-serviceable parts are inside. Damaged or suspected inoperative equipment must be immediately removed from use and must be checked/repaired by qualified service personnel prior to continued use.
•
This device is not recommended for use in the presence of imaging equipment such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) devices, etc.
•
The following equipment may cause interference with the RF channel: microwave ovens, diathermy units with LANs (spread spectrum), amateur radios, and government radar.
•
When necessary, dispose of the device, its components and accessories (e.g., batteries, cables, electrodes), and/or packing materials in accordance with local regulations.
•
AA batteries are known to leak their contents when stored in unused equipment. Remove battery from device when not used for an extended period of time.
•
Be careful to insert the connector block into the appropriate input connector by matching the lead wire labels to the device label.
•
To prevent possible damage to the device during transport and storage (while in original packaging) the following environmental conditions must be adhered to: Ambient Temperature Range: Relative Humidity Range: Atmosphere Pressure:
●
-20°C to 65°C (-4°F to 149°F) 5% to 95% (non-condensing) 500 hPa to 1060 hPa
This device is intended to be used in a hospital or doctor’s office setting, and should be used according to the environmental conditions specified below: Ambient Temperature Range: Relative Humidity Range: Atmosphere Pressure:
0°C to 40°C (32°F to 104°F) 5% to 95% (non-condensing) 500 hPa to 1060 hPa
7
USER SAFETY INFORMATION
FCC Compliance Statement In the United States use of this device is regulated by the Federal Communications Commission (FCC). The device with its antenna complies with FCC’s RF exposure limits for general population/uncontrolled exposure. FCC Warning (Part 15.21): Changes or modifications not expressly approved by the party responsible for compliance could void the user’s authority to operate the device. WAM FCC ID: HJR-WAM2500 UTK FCC ID: HJR-UTK2500 These devices comply with Part 15 of the FCC rules. Operation is subject to the following conditions: 1. This device may not cause harmful interference, and 2. This device must accept any interference received, including interference that may cause undesired operation.
Industry Canada Compliance Statement These devices comply with RSS-210 of the Industry Canada rules. Operation is subject to the following two conditions: 1. This device may not cause interference, and 2. This device must accept any interference, including interference that may cause undesired operation of the device. WAM IC: UTK IC:
3758B-WAM2500 3758B-UTK2500
The term “IC:” before the certification/registration number only signifies that the Industry Canada technical specifications were met.
8
USER SAFETY INFORMATION
Note(s) •
Proper patient preparation is important to proper application of ECG electrodes and operation of the device.
•
If electrode is not properly connected to the patient, or one or more of the patient cable lead wires is damaged, display will indicate a lead fault for the lead(s) where the condition is present.
•
WAM™ (wireless acquisition module) must be paired to electrocardiograph before operation. If you possess more than one WAM, you are advised to label it and the paired electrocardiograph in order to avoid confusion. A sheet of labels is provided with the WAM for convenience.
•
For additional instructions and warnings, refer to the user manual of the receiving device.
•
As defined by IEC 60601-1 and IEC 60601-2-25, the device is classified as follows: • Class I equipment or internally powered. • Type CF (ECG) defibrillation-proof applied parts. • Equipment not suitable for use in the presence of a flammable anesthetic mixture. • Continuous operation.
•
The device will automatically start flashing LEDs if the batteries have been discharged below 1.0 volts.
•
During normal operation, the green LED will display continuously.
•
If the battery cover is opened during transmission, the device will stop transmitting. The battery must be reinserted and the cover must be applied to resume operation.
•
The device will automatically turn off (LEDs off) if the battery has been severely discharged.
•
The device will automatically turn off when the electrocardiograph is powered down.
•
The device will automatically turn off (LEDs off) after two minutes of inactivity or user input. The device will turn off immediately if the device battery has been severely discharged.
•
When using the ELI 350, switching to a direct patient cable will automatically power down the device.
•
When pairing with the device ensure the AM12 has been disconnected or the pairing operation will fail.
•
To perform a STAT ECG using the device paired with an ELI 230 electrocardiograph, user must select STAT at the electrocardiograph to continue.
•
A square wave presentation on the display while using the WAM may be due to the WAM being turned off, having no battery, not being paired correctly, operating out of range, or due to a calibration error. Review the LED indicator and auditory advisory on the WAM to ensure the unit is turned on, has proper battery level, is paired correctly, and is within recommended proximity of the electrocardiograph, or power cycle the WAM to re-calibrate.
•
The device is UL classified: WITH RESPECT TO ELECTRIC SHOCK, FIRE AND MECHANICAL HAZARDS ONLY IN ACCORDANCE WITH UL2601-1, IEC60601-1, CAN/CSA CC22.2 No. 601.1, IEC60601-2-25,
9
USER SAFETY INFORMATION
10
EQUIPMENT SYMBOLS AND MARKINGS Symbol Delineation Defibrillation protection in patient cable
General Warning
Defibrillator-proof type CF applied part
Acquire 12 Lead ECG
Acquire Rhythm Print
On / Off button
Battery with notification: See operating instructions for type of cell to be used
Do not dispose as unsorted municipal waste. Per European Union Directive 2002/96, requires separate handling for waste disposal according to national requirements
Indicates compliance to applicable European Union directives
11
GENERAL CARE Precautions • • •
Turn off the device before inspecting or cleaning. Do not immerse the device in water. Do not use organic solvents, ammonia-based solutions, or abrasive cleaning agents which may damage equipment surfaces.
Inspection Inspect your equipment daily prior to operation. If you notice anything that requires repair, contact an authorized service person to make the repairs. • Verify that all cables and connectors are securely seated. • Check the case for any visible damage. • Inspect cables and connectors for any visible damage. • Inspect buttons and controls for proper function and appearance.
Sterilization Do not sterilize the device or patient cables with Ethylene Oxide (EtO) gas.
Cautions Improper cleaning products and processes can damage the device, produce brittle lead wires and cables, corrode the metal, and void the warranty. Use care and proper procedure whenever cleaning or maintaining the device.
12
ELECTROMAGNETIC COMPATIBILITY (EMC) Electromagnetic compatibility with surrounding devices should be assessed when using the device. An electronic device can either generate or receive electromagnetic interference. Testing for electromagnetic compatibility (EMC) has been performed on the device according to the international standard for EMC for medical devices (IEC 60601-1-2). This IEC standard has been adopted in Europe as the European Norm (EN 60601-1-2). The device should not be used adjacent to, or stacked on top of other equipment. If the device must be used adjacent to or stacked on top of other equipment, verify that the device operates in an acceptable manner in the configuration in which it will be used. Fixed, portable, and mobile radio frequency communications equipment can affect the performance of medical equipment. See appropriate EMC table for recommended separation distances between the radio equipment and the device. The use of accessories, transducers, and cables other than those specified by Mortara Instrument may result in increased emissions or decreased immunity of the equipment.
13
ELECTROMAGNETIC COMPATIBILITY (EMC)
Guidance and Manufacturer’s Declaration: Electromagnetic Emissions The equipment is intended for use in the electromagnetic environment specified in the table below. The customer or the user of the equipment should ensure that it is used in such an environment. Emissions Test
Compliance
Electromagnetic Environment: Guidance
RF Emissions CISPR 11
Group 1
The equipment must emit electromagnetic energy in order to perform its intended function. Nearby electronic equipment may be affected.
RF Emissions CISPR 11
Class B
Harmonic Emissions IEC 61000-3-2
Not Applicable
The equipment is suitable for use in all establishments including domestic establishments and those directly connected to the public low-voltage power supply network that supplies buildings used for domestic purposes.
Voltage Fluctuations/ Flicker Emissions IEC 61000-3-3
Not Applicable
Guidance and Manufacturer’s Declaration: Electromagnetic Immunity The equipment is intended for use in the electromagnetic environment specified in the table below. The customer or the user of the equipment should ensure that it is used in such an environment. Emissions Test
Compliance
Compliance Level
Electromagnetic Environment: Guidance
Electrostatic discharge (ESD) IEC 61000-4-2
+/- 6 kV contact +/- 8 kV air
+/- 6 kV contact +/- 8 kV air
Floors should be wood, concrete, or ceramic tile. If floors are covered with synthetic material, the relative humidity should be at least 30%.
Electrical fast transient/burst IEC 61000-4-4
+/- 2 kV for power supply lines +/- 1 kV for input/output lines
Not Applicable
Surge IEC 61000-4-5
+/- 1 kV differential mode +/- 2 kV common mode
Not Applicable
Voltage dips, short interruptions, and voltage variations on power supply input lines IEC 61000-4-11
<5% UT (>95% dip in UT) for 0.5 cycle 40% UT (60% dip in UT) for 5 cycles
Not Applicable
Power frequency (50/60 Hz) magnetic field
3 A/m
3 A/m
Power frequency magnetic fields should be at levels characteristic of a typical location in a typical commercial or hospital environment.
NOTE: UT is the AC Mains voltage prior to application of the test level.
14
ELECTROMAGNETIC COMPATIBILITY (EMC)
Guidance and Manufacturer’s Declaration: Electromagnetic Immunity The equipment is intended for use in the electromagnetic environment specified in the table below. The customer or the user of the equipment should ensure that it is used in such an environment. Emissions Test
IEC 60601 Test Level
Compliance Level
Electromagnetic Environment: Guidance Portable and mobile RF communications equipment should be used no closer to any part of the equipment, including cables, than the recommended separation distance calculated from the equation applicable to the frequency of the transmitter. Recommended separation distance
Conducted RF IEC 61000-4-6
Radiated RF IEC 61000-4-3
3 Vrms 150 kHz to 80 MHz
3 V/m 80 MHz to 2.5 GHz
3 Vrms 150 kHz to 80 MHz
3 V/m 80 MHz to 2.5 GHz
3.5 P d= 3Vrms
3.5 d= P 3V / m
80 MHz to 800 MHz
7 d= P 3V / m
800 MHz to 2.5 GHz
Where P is the maximum output power rating of the transmitter in watts (W) according to the transmitter manufacturer and d is the recommended separation distance in meters (m). Field strengths from fixed RF transmitters, as determined by an electromagnetic site surveya, should be less than the compliance level in each frequency rangeb. Interference may occur in the vicinity of equipment marked with the following symbol:
NOTE 1: At 800 MHz, the separation distance for the higher frequency range applies. NOTE 2: These guidelines may not apply in all situations. Electromagnetic propagation is affected by the absorption and reflection from structures, objects, and people. a. Field strengths from fixed transmitters, such as base stations for radio (cellular/cordless) telephones and land mobile radios, amateur radios, AM and FM radio broadcast, and TV broadcast cannot be predicted theoretically with accuracy. To assess the electromagnetic environment due to fixed RF transmitters, an electromagnetic site survey should be considered. If the measured field strength in the location in which the equipment is used exceeds the applicable RF compliance level above, the equipment should be observed to verify normal operation. If abnormal performance is observed, additional measures may be necessary, such as reorienting or relocating the equipment. b. Over the frequency range 150 kHz to 80 MHz, field strengths should be less than [3] V/m.
15
ELECTROMAGNETIC COMPATIBILITY (EMC)
Recommended Separation Distances Between Portable and Mobile RF Communications Equipment and the Equipment The equipment is intended for use in the electromagnetic environment in which radiated RF disturbances are controlled. The customer or the user of the equipment can help to prevent electromagnetic interference by maintaining a minimum distance between portable and mobile RF communications equipment (transmitters) and the equipment as recommended in the table below, according to the maximum output power of the communications equipment. Rated Maximum Output Power of Transmitter W
Separation Distance According to Frequency of Transmitter (m)
150 kHz to 80 MHz
80 MHz to 800 MHz
800 MHz to 2.5 GHz
d = 1.2 P
d = 1.2 P
d = 2.3 P
0.01
0.1 m
0.1 m
0.2 m
0.1
0.4 m
0.4 m
0.7 m
1
1.2 m
1.2 m
2.3 m
10
4.0 m
4.0 m
7.0 m
100
12.0 m
12.0 m
23.0 m
For transmitters rated at a maximum output power not listed above, the recommended separation distance d in meters (m) can be estimated using the equation applicable to the frequency of the transmitter, where P is the maximum output power rating of the transmitter in watts (W) according to the transmitter manufacturer. NOTE 1: At 800 MHz, the separation distance for the higher frequency range applies. NOTE 2: These guidelines may not apply in all situations. Electromagnetic propagation is affected by the absorption and reflection from structures, objects, and people.
16